BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12759537)

  • 1. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
    Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
    Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
    Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study.
    Nagler RM; Kerner H; Laufer D; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Cancer Lett; 2002 Dec; 186(2):137-50. PubMed ID: 12213283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands.
    Yin HF; Okada N; Takagi M
    Pathol Int; 2000 Aug; 50(8):603-9. PubMed ID: 10972857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TUNEL - an efficient prognosis predictor of salivary malignancies.
    Ben-Izhak O; Laster Z; Araidy S; Nagler RM
    Br J Cancer; 2007 Apr; 96(7):1101-6. PubMed ID: 17325701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
    Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
    Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
    Al-Rawi NH; Omer H; Al Kawas S
    J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A; Margaria E; Chiusa L
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis.
    Nakanishi H; Ohsawa M; Naka N; Uchida A; Ochi T; Aozasa K
    Oncology; 1997; 54(3):238-44. PubMed ID: 9143406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.
    de Krijger RR; van der Harst E; van der Ham F; Stijnen T; Dinjens WN; Koper JW; Bruining HA; Lamberts SW; Bosman FT
    J Pathol; 1999 May; 188(1):51-5. PubMed ID: 10398140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
    Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
    J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2 and salivary cancer.
    Ben-Izhak O; Akrish S; Gan S; Nagler RM
    Cancer Biol Ther; 2009 Jan; 8(2):153-8. PubMed ID: 19029817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.